| HOME >> BIOLOGY >> TECHNOLOGY |
-------------------------------------------------------------------------
31,598,829 30,799,271
-------------------------------------------------------------------------
33,896,893 33,565,692
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Oncolytics Biotech Inc.
STATEMENTS OF LOSS AND COMPREHENSIVE LOSS
(unaudited)
Cumulative
from
Nine Month Nine Month Three Month Three Month inception
Period Period Period Period on April 2,
Ending Ending Ending Ending 1998 to
September September September September September
30, 2007 30, 2006 30, 2007 30, 2006 30, 2007
$ $ $ $ $
-------------------------------------------------------------------------
Revenue
Rights revenue - - - - 310,000
-------------------------------------------------------------------------
- - - - 310,000
-------------------------------------------------------------------------
Expenses
Research and
development 8,815,255 6,582,687 2,890,644 2,705,746 52,036,449
Operating 2,798,630 2,789,647 880,158 766,618 19,569,211
Stock-based
compensation 142,878 293,880 38,909 34,671 4,308,527
Foreign
'/>"/>| SOURCE Oncolytics Biotech Inc. Copyright©2007 PR Newswire. All rights reserved |